Q linea AB (ST:QLINEA) — Market Cap & Net Worth
Market Cap & Net Worth: Q linea AB (QLINEA)
Q linea AB (ST:QLINEA) has a market capitalization of $34.46 Million (Skr320.23 Million) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #23243 globally and #443 in its home market, demonstrating a -19.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Q linea AB's stock price Skr16.90 by its total outstanding shares 18948752 (18.95 Million). Analyse how efficiently does Q linea AB generate cash to see how efficiently the company converts income to cash.
Q linea AB Market Cap History: 2018 to 2026
Q linea AB's market capitalization history from 2018 to 2026. Data shows change from $123.37 Million to $34.46 Million (-17.05% CAGR).
Q linea AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Q linea AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.58x
Q linea AB's market cap is 4.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $123.37 Million | $1.07 Million | -$128.35 Million | 115.73x | N/A |
| 2019 | $117.25 Million | $1.00 Million | -$178.06 Million | 116.67x | N/A |
| 2020 | $346.66 Million | $243.00K | -$220.19 Million | 1426.59x | N/A |
| 2021 | $230.43 Million | $9.34 Million | -$233.18 Million | 24.68x | N/A |
| 2022 | $21.41 Million | $12.79 Million | -$275.77 Million | 1.67x | N/A |
| 2023 | $7.54 Million | $4.44 Million | -$229.37 Million | 1.70x | N/A |
| 2024 | $1.41 Million | $2.36 Million | -$216.87 Million | 0.60x | N/A |
| 2025 | $50.86 Million | $11.10 Million | -$182.49 Million | 4.58x | N/A |
Competitor Companies of QLINEA by Market Capitalization
Companies near Q linea AB in the global market cap rankings as of May 4, 2026.
Key companies related to Q linea AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Q linea AB Historical Marketcap From 2018 to 2026
Between 2018 and today, Q linea AB's market cap moved from $123.37 Million to $ 34.46 Million, with a yearly change of -17.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr34.46 Million | -32.24% |
| 2025 | Skr50.86 Million | +3514.49% |
| 2024 | Skr1.41 Million | -81.35% |
| 2023 | Skr7.54 Million | -64.76% |
| 2022 | Skr21.41 Million | -90.71% |
| 2021 | Skr230.43 Million | -33.53% |
| 2020 | Skr346.66 Million | +195.65% |
| 2019 | Skr117.25 Million | -4.96% |
| 2018 | Skr123.37 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Q linea AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $34.46 Million USD |
| MoneyControl | $34.46 Million USD |
| MarketWatch | $34.46 Million USD |
| marketcap.company | $34.46 Million USD |
| Reuters | $34.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Q linea AB
Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, European Union, the Middle East, and the United States. It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, includin… Read more